A fully funded four year PhD project at Newcastle University will focus on the development and validation of quantitative assays for nephritic factors in complement mediated kidney disease.
Based within the National Renal Complement Therapeutics Centre and Complement Therapeutic Research Group, this project offers a bench to bedside research environment integrating clinical care, advanced genetic testing and translational science. You will be supervised by David Kavanagh, Neil Sheerin and Kevin Marchbank.
The project will involve developing assays to detect and quantify autoantibodies known as nephritic factors, which drive excessive complement activation and kidney damage. You will use a range of immunological and protein based techniques, working with international collaborators, and apply these assays to patient samples to better understand disease activity and outcomes.
The assays developed are expected to be adopted into clinical care and support the design of future clinical trials for emerging treatments in complement mediated disease.
You will gain experience in laboratory immunology and protein biology techniques within a translational research setting, with insight into the link between laboratory discovery and clinical application.
Informal enquiries can be made to David Kavanagh (David.Kavanagh@ncl.ac.uk) or Kevin Marchbank (Kevin.Marchbank@ncl.ac.uk).
Funding: UKRI stipend (indicative £21,805 per year) plus tuition fees and research costs for four years (UK students).